Mercy Bioanalytics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
22 Strathmore Rd Ste 415, Natick, Massac...Website
www.mercybio.comRevenue
$10.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Mercy Bioanalytics
Mercy BioAnalytics, Inc. is a biotechnology company committed to reducing suffering and saving lives through the early detection of cancer. Using nanoparticles that are extraordinarily abundant in blood and carry information about their parent cell known as extracellular vesicles, or EVs the company has developed an approach that is showing tremendous promise in detecting early-stage cancer, when it is most treatable. The company's initial focus is on early detection of difficult-to-treat cancers, such as ovarian and lung, which today are often found too late to save lives.Explore more
Mercy Bioanalytics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mercy Bioanalytics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Mercy Bioanalytics has new funding data
Earning: See what the market has to say on Mercy Bioanalytics recently announced quarterly report
Mercy Bioanalytics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Mercy Bioanalytics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Mercy Bioanalytics
Check out if Mercy Bioanalytics is spiking on competitors!
Product Launch: Get notified when Mercy Bioanalytics launches new products
Click to see if Mercy Bioanalytics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Mercy Bioanalytics
Compare insights from companies similar to Mercy Bioanalytics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$22.2M
51-200
Private
$10M
2015
AD
Alicia DillardAssociate Clinical Laboratory Director and Molecular Pathologist
Company Profile Activity
Activity Insights
Mercy Bioanalytics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Mercy Bioanalytics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Mercy Bioanalytics.
Mercy Bioanalytics financials insights
Gather financial insights about Mercy Bioanalytics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$41M
2025
Series B
$59M
Mercy Bioanalytics Tech Stack
A closer look at the technologies used by Mercy Bioanalytics
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Open Position
New Hire
Executive Move
Executive Moves, New Hire
Open Position
Funding
Funding
Mercy Bioanalytics News & Media
Mercy BioAnalytics Appoints Darrin Crisitello as Chief Commercial Officer
WALTHAM, Mass., Feb. 4, 2026 /PRNewswire/ -- Mercy BioAnalytics, Inc. ("Mercy"), a leader in advancing earlier and more accurate cancer detection, today announced the appointment of Darrin Crisitello as Chief Commercial Officer. Mr. Crisitello will lead the company's global commercial...Mercy BioAnalytics Appoints Ellen Snow as Chief Financial Officer
WALTHAM, Mass., Dec. 4, 2025 /PRNewswire/ -- Mercy BioAnalytics, a company dedicated to reducing suffering and saving lives through the early detection of cancer, today announced the appointment of Ellen Snow as its Chief Financial Officer. Snow will lead Mercy's enterprise financial,...Mercy Halo Blood Test Shows Promise in Early Lung Cancer Detection: New Study Shows Performance Similar to LDCT with Clinical Complementarity
WALTHAM, Mass., Nov. 20, 2025 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in blood-based detection of early-stage cancer, today announced data from a groundbreaking study leveraging samples from the National Lung Screening Trial (NLST). The study results suggest that the Mercy...Mercy BioAnalytics Publishes Validation Study in Gynecologic Oncology Demonstrating Unprecedented Performance of Blood Test for Early Detection of Ovarian Cancer
Test demonstrates 89% sensitivity for detection of preclinical stage I/II high grade serous ovarian cancer at 98% specificity in average risk postmenopausal women WALTHAM, Mass., Oct. 28, 2025 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in blood-based detection of early-stage...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mercy Bioanalytics
Sign Up For FreeTo access detailed company insights
Mercy BioAnalytics, Inc. is a biotechnology company committed to reducing suffering and saving lives through the early detection of cancer. Using nanoparticles that are extraordinarily abundant in blood and carry information about their parent cell known as extracellular vesicles, or EVs the company has developed an approach that is showing tremend... Read More
